174 related articles for article (PubMed ID: 26966924)
1. Addressing challenges for sustainable healthcare in Central and Eastern Europe.
Godman B; Novakovic T; Tesic D; Oortwijn W; Martin AP; Parker M; Haycox A
Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):685-687. PubMed ID: 26966924
[TBL] [Abstract][Full Text] [Related]
2. The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia.
Novakovic T; Martin AP; Parker M; Ferrario A; Vukovic S; Łanda K; Duba J; Dankó D; Kotsopoulos N; Godman B; Ristic J; Stefanovic D; Tesic D
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):519-521. PubMed ID: 28946800
[TBL] [Abstract][Full Text] [Related]
3. Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries.
Zelei T; Molnár MJ; Szegedi M; Kaló Z
Orphanet J Rare Dis; 2016 Jun; 11(1):72. PubMed ID: 27259284
[TBL] [Abstract][Full Text] [Related]
4. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
Front Public Health; 2020; 8():612410. PubMed ID: 33490024
[No Abstract] [Full Text] [Related]
5. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
Huic M; Tandara Hacek R; Svajger I
Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
[TBL] [Abstract][Full Text] [Related]
6. HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain.
Gulácsi L; Péntek M
Eur J Health Econ; 2014 Sep; 15(7):675-80. PubMed ID: 24828321
[No Abstract] [Full Text] [Related]
7. Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019.
Inotai A; Németh B
Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):379-381. PubMed ID: 31159614
[No Abstract] [Full Text] [Related]
8. Drug Policies in Central and Eastern European Countries.
Janhz-Różyk K; Kawalec P; Szkultecka-Debek M
Value Health Reg Issues; 2017 Sep; 13():59-60. PubMed ID: 29073990
[No Abstract] [Full Text] [Related]
9. Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.
Jönsson B; Hampson G; Michaels J; Towse A; von der Schulenburg JG; Wong O
Eur J Health Econ; 2019 Apr; 20(3):427-438. PubMed ID: 30229376
[TBL] [Abstract][Full Text] [Related]
10. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
[TBL] [Abstract][Full Text] [Related]
11. Striking a balance between national interests and patients' needs: cross-border projects meeting European challenges.
Burger R; Kostera T
World Hosp Health Serv; 2010; 46(4):4-6. PubMed ID: 21391444
[TBL] [Abstract][Full Text] [Related]
12. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
13. Aid programmes in eastern Europe. Can we learn from Third World experience?
Maxwell G
J R Soc Health; 1995 Jun; 115(3):150-2. PubMed ID: 7643339
[TBL] [Abstract][Full Text] [Related]
14. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities in Pan-European collaboration for researchers from Central and Eastern Europe.
Decsi T; Fidler Mis N; Kolacek S; Kon I; Kopecky J; Penas-Jimenez I; Socha P; Szajewska H
Adv Exp Med Biol; 2005; 569():54-9. PubMed ID: 16137107
[TBL] [Abstract][Full Text] [Related]
16. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C
Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440
[TBL] [Abstract][Full Text] [Related]
17. EUnetHTA's contribution to the new legal framework for health technology assessment cooperation in Europe.
Imaz-Iglesia I; Wild C
Int J Technol Assess Health Care; 2022 Jun; 38(1):e50. PubMed ID: 35652661
[TBL] [Abstract][Full Text] [Related]
18. OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.
Németh B; Csanádi M; Kaló Z
Int J Technol Assess Health Care; 2017 Jan; 33(3):333-338. PubMed ID: 28434433
[TBL] [Abstract][Full Text] [Related]
19. Health technology assessment and health care in the European Union.
Banta D; Oortwijn W
Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
[TBL] [Abstract][Full Text] [Related]
20. Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers.
Kamusheva M; Németh B; Zemplényi A; Kaló Z; Elvidge J; Dimitrova M; Pontén J; Tachkov K; Mitkova Z
J Comp Eff Res; 2022 Aug; 11(12):905-913. PubMed ID: 35726611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
